Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: resembling (46)

Fluorouracil-Mitomycin-Radiotherapy

Description: Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL-MITOMYCIN-RADIOTHERAPY Regimen • Colorectal Cancer – Fluorouracil-Mitomycin-Radiotherapy Indication • Squamous cell carcinoma of the anus • WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-Mitomycin-Radiotherapy.pdf

Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL, FOLINIC ACID (Modified de Gramont) and IRINOTECAN (FOLFIRI) Regimen • Colorectal Cancer– Fluorouracil, Folinic Acid (Modified de
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-FolinicAcid-Irinotecan.pdf

Fluorouracil-Folinic acid(MdG)-Irinotecan-Panitumumab

Description: Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL, FOLINIC ACID (Modified de Gramont), IRINOTECAN and PANITUMUMAB (FOLFIRI-Panitumumab) This protocol may require funding Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-Folinic-acidMdG-Irinotecan-Panitumumab.pdf

Cetuximab-Irinotecan (14 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-IRINOTECAN (14 day) This regimen may require funding Regimen • Colorectal Cancer–Cetuximab-Irinotecan (14 day) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Irinotecan14day.pdf

Cetuximab (7 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB (7 day) This regimen may require funding Regimen • Colorectal Cancer – Cetuximab (7 day) Indication • Metastatic colorectal
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab7day.pdf

Cetuximab (14 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB (14 day) This regimen may require funding Regimen • Colorectal Cancer – Cetuximab (14 day) Indication • Metastatic colorectal
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab14day.pdf

Capecitabine-Radiotherapy

Description: Chemotherapy Protocol PANCREATIC CANCER CAPECITABINE (RADIOTHERAPY) Regimen • Pancreatic Cancer – Capecitabine (Radiotherapy) Indication • Locally advanced, non-metastatic pancreatic cancer • WHO performance status
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Capecitabine-Radiotherapy.pdf

Capecitabine-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and OXALIPLATIN (CAPOX) Regimen • Colorectal Cancer – Capecitabine-Oxaliplatin (CAPOX) Indication • Advanced / metastatic colorectal cancer • Adjuvant therapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Oxaliplatin.pdf

Capecitabine-Mitomycin

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-MITOMYCIN Regimen • Colorectal Cancer – Capecitabine-Mitomycin Indication • Second / third line therapy of metastatic/advanced colorectal cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Mitomycin.pdf

Capecitabine-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and IRINOTECAN (XELIRI) Regimen • Colorectal Cancer– Capecitabine-Irinotecan (XELIRI) Indication • Treatment of advanced colorectal cancer • WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Irinotecan.pdf

561 to 570 of 761

Previous … 55 56 57 58 59 … Next